Specifically, in IDH mutant gliomas, this subregion more likely corresponds to low-malignancy tissues with relatively high vascular integrity, which may be attributed to the fact that the IDH mutation regulates downstream cytoskeletal protein (like Tau), inhibiting angiogenesis and promoting vascular normalization [7, 31]. Here, DNM2 is linked to central nervous system cancer.